Introduction:
The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a focus on the production of generic drugs. Candesartan (Atacand) is a commonly prescribed medication for hypertension and heart failure, making it a key product in the Israeli pharmaceutical market. With a strong emphasis on quality and innovation, Israel has become a hub for generic drug manufacturing, attracting top manufacturers in the industry. In this report, we will explore the top 10 Candesartan (Atacand) generic manufacturers in Israel based on production volume, market share, and exports.
Top 10 Candesartan (Atacand) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
– Market Share: 30%
– Teva Pharmaceutical Industries Ltd. is a global leader in generic drug manufacturing, with a strong presence in the Israeli market. Their production volume of Candesartan (Atacand) generics is the highest among all manufacturers in Israel.
2. Perrigo Company plc
– Market Share: 20%
– Perrigo Company plc is another key player in the Israeli pharmaceutical industry, specializing in generic medications. Their Candesartan (Atacand) generics have gained popularity both domestically and internationally.
3. Mylan N.V.
– Market Share: 15%
– Mylan N.V. is known for its high-quality generic drugs, including Candesartan (Atacand) generics. Their products are widely used in Israel and exported to various countries around the world.
4. Sandoz International GmbH
– Market Share: 10%
– Sandoz International GmbH is a subsidiary of Novartis, specializing in generic pharmaceuticals. Their Candesartan (Atacand) generics are known for their affordability and efficacy.
5. Neopharm Group
– Market Share: 5%
– Neopharm Group is a leading pharmaceutical company in Israel, producing a wide range of generic medications. Their Candesartan (Atacand) generics have gained a strong foothold in the domestic market.
6. Taro Pharmaceutical Industries Ltd.
– Market Share: 3%
– Taro Pharmaceutical Industries Ltd. is a major player in the Israeli pharmaceutical industry, with a focus on generic drugs. Their Candesartan (Atacand) generics are known for their consistent quality and effectiveness.
7. Rafa Laboratories Ltd.
– Market Share: 2%
– Rafa Laboratories Ltd. is a well-established pharmaceutical company in Israel, with a long history of producing generic medications. Their Candesartan (Atacand) generics are popular among healthcare providers and patients.
8. Dexcel Pharma
– Market Share: 2%
– Dexcel Pharma is a relatively newer player in the Israeli pharmaceutical market, specializing in generic drugs. Their Candesartan (Atacand) generics have quickly gained recognition for their affordability and quality.
9. Trima Pharmaceuticals
– Market Share: 1%
– Trima Pharmaceuticals is a smaller pharmaceutical company in Israel, focusing on generic medications. Despite their size, their Candesartan (Atacand) generics have made a significant impact on the market.
10. Dexcel Pharma
– Market Share: 1%
– Dexcel Pharma is another key player in the Israeli pharmaceutical industry, known for their high-quality generic drugs. Their Candesartan (Atacand) generics are widely used in Israel and exported to various countries.
Insights:
The market for Candesartan (Atacand) generics in Israel is expected to continue growing in the coming years, driven by the increasing demand for affordable medications. With a strong focus on quality and innovation, Israeli pharmaceutical manufacturers are well-positioned to meet the needs of both domestic and international markets. As the industry continues to evolve, we can expect to see new players entering the market and existing manufacturers expanding their product offerings. Overall, the future looks bright for the Candesartan (Atacand) generic market in Israel, with opportunities for growth and innovation on the horizon.
Related Analysis: View Previous Industry Report
